WorldPreclinicalCongress.com
June 12-16, 2017 | The Westin Copley Place, Boston, MA
WORLD PRECLINICAL
CONGRESS
16
th
Annual
MEDICINAL CHEMISTRY
Mastering Medicinal Chemistry - Part 1
Mastering Medicinal Chemistry - Part 2
ONCOLOGY
Preclinical Models and Tools in Oncology - Part 1
Tumor Models for Cancer Immunotherapy - Part 2
Cancer Immunotherapy and Combinations
Immuno-Oncology Targets
SCREENING
Phenotypic Screening and Chemical Biology
CRISPR for Target Discovery
3D Cellular Models
PLENARY KEYNOTE PROGRAM
Human Organs-On-Chips
Donald E. Ingber, M.D., Ph.D., Founding Director, Wyss
Institute for Biologically Inspired Engineering, Harvard
University; Judah Folkman Professor of Vascular Biology,
Harvard Medical School & Boston Children's Hospital; and
Professor of Bioengineering, John A. Paulson School of
Engineering & Applied Sciences, Harvard University
Preclinical and Translation Studies to Support the
Anti-PD1 Antibody, Keytruda
Michael Rosenzweig, D.V.M., Ph.D., Executive Director,
Oncology-Discovery, Merck Research Laboratories
DISCOVERY & DEVELOPMENT
Predicting Drug Toxicity
Blood-Brain Barrier
Translational Strategies in CNS
SYMPOSIA
iPS Cells for Disease Modeling and Drug Discovery
New Tools for Disease Modeling
Phenotypic and Genotypic Cell Analysis in
Immuno-Oncology
Nano-Delivery: Nucleic Acids, Cancer
Immunotherapy and Beyond
Property-Based Drug Design
TRAINING SEMINAR
Applying Pharmacology to New Drug Discovery
CONFERENCE PROGRAMS
PLENARY KEYNOTE PANEL:
Insights on Innovative Technologies Enabling
Preclinical Research
Moderator: Leigh Zawel, Vice President and Site Head, New York
and Boston Centers for Therapeutic Innovation, Pfizer
Panelists:
Matt Gevaert, Ph.D., CEO and Co-Founder, KIYATEC
Pradip Majumder, Ph.D., CSO, Mitra Biotech
David Hutto, Ph.D., DVM, DACVP, CSO, Vium
Daniel Kagan, Ph.D., COO, Scientist
Where Preclinical Minds Meet Discovery Technologies
FINAL WEEKS
TO REGISTER!